MethylprednisoloneTumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1837卷 / 1期

关键词：

D O I：

10.1007/s40278-021-89041-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：442 / 442

相关论文

共 50 条

[21] VismodegibTumour lysis syndrome: case report
Reactions Weekly, 2019, 1767 (1) : 303 - 303
[22] MitotaneTumour lysis syndrome: case report
Reactions Weekly, 2019, 1748 (1) : 350 - 350
[23] DoxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2013, 1482 (1) : 20 - 20
[24] BortezomibTumour lysis syndrome: case report
Reactions Weekly, 2021, 1872 (1) : 103 - 103
[25] DocetaxelTumour lysis syndrome: case report
Reactions Weekly, 2018, 1694 (1) : 179 - 179
[26] AntineoplasticsTumour lysis syndrome: case report
Reactions Weekly, 2019, 1735 (1) : 38 - 38
[27] AtezolizumabTumour lysis syndrome: case report
Reactions Weekly, 2019, 1769 (1) : 74 - 74
[28] ImatinibTumour lysis syndrome: case report
Reactions Weekly, 2009, 1238 (1) : 18 - 18
[29] HydroxycarbamideTumour lysis syndrome: case report
Reactions Weekly, 2021, 1863 (1) : 180 - 180
[30] RuxolitinibTumour lysis syndrome: case report
Reactions Weekly, 2017, 1671 (1) : 347 - 347

← 1 2 3 4 5 →